ArticlePain and therapy2022

Comparative Benefit-Risk Assessment for Lidocaine 700 mg Medicated Plaster and Pregabalin in Peripheral Neuropathic Pain Following a Structured Framework Approach.

Ingo Sabatschus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.